Revenue

SOCRadar's 'Best Workplace' award isn't just an HR win. It's the strategic core fueling its AI innovation and rapid growth in a talent-starved industry.

Bluejay Diagnostics secures critical funding to advance its rapid sepsis test, extending its cash runway but raising questions about shareholder dilution.

A simple game of Solitaire is now a tool for marine conservation. It's the new frontier where entertainment meets impact, mobilizing millions for the planet.

Stonegate Capital's updated coverage validates AB Science's pivot to ALS and AML, but can its promising clinical assets and shrewd financing de-risk the path forward?

A new platform, Chimney Collective, is rolling up local chimney service providers. With a 'brain trust' advisory board, it's a classic private equity play.

With $11M from a16z, Westmag is building a domestic supply of drone motors and robot actuators, tackling a critical national security vulnerability.

A pivotal partnership between WeInfuse and Trial IQ leverages AI to bring clinical trials to local infusion centers, signaling a major shift in drug development.

That $1 trillion pile of unused loyalty points may soon be spendable cash. A tech firm, backed by The Points Guy, is turning rewards into a currency.

A record-breaking loan for a Four Seasons project with no hotel signals a profound shift in how the ultra-wealthy live, and how Austin is being remade.

A new Sunnyvale service claims it can turn AI hardware concepts into investor-ready demos in just 21 days, attacking the notorious development bottleneck.

The refrigerated section is no longer just for basics. It's a hub for innovation where protein, convenience, and global flavors are reshaping our diets.

NexTel Medical acquires two telehealth firms for an instant $135K in monthly revenue, aiming to launch its Maxasome™ exosome therapies to 1,850 clinics.

Static PDFs and fragmented sales pitches are failing. A new class of AI-guided platforms is helping buyers build trust on their own terms. What does this mean?

As Vallarta Supermarkets expands to Merced, it reveals a masterclass in durable growth: a strategy built not on price wars, but on deep community integration.

A small startup just raised $4M to solve the biggest problem in tech: making AR glasses affordable. Their secret isn't a new gadget, but a materials science breakthrough.

Crosslist moves beyond software with a guide for resellers, a strategic play to capture the booming resale market by teaching the trade before selling the tool.

As its CEO heads to a top investor conference, Zealand Pharma leverages AI and novel peptides to challenge giants in the multi-billion-dollar obesity market.

A new platform, Risk Monitor, automates the tracking of permits, community sentiment, and environmental data to help developers stay ahead of project-killing risks.

A new study reveals an 'early warning system' in infant guts, offering a window to combat the atopic march before allergies take hold. Is this the future?

The tech-forward wealth platform is integrating alternative assets, margin, and options, challenging legacy players and democratizing access to elite strategies.